
Company Number
10887014
Next Accounts
Dec 2025
Shareholders
-
Group Structure
View All
Industry
Other human health activities
Registered Address
215 euston road, london, NW1 2BE
Website
hdruk.ac.ukPomanda estimates the enterprise value of HEALTH DATA RESEARCH UK at £6.7m based on a Turnover of £11.2m and 0.6x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of HEALTH DATA RESEARCH UK at £0 based on an EBITDA of £-6.7m and a 4.52x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of HEALTH DATA RESEARCH UK at £178m based on Net Assets of £79.7m and 2.23x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Health Data Research Uk is a live company located in london, NW1 2BE with a Companies House number of 10887014. It operates in the other human health activities sector, SIC Code 86900. Founded in July 2017, it's largest shareholder is unknown. Health Data Research Uk is a young, mid sized company, Pomanda has estimated its turnover at £11.2m with declining growth in recent years.
Pomanda's financial health check has awarded Health Data Research Uk a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
4 Weak
Size
annual sales of £11.2m, make it larger than the average company (£731.1k)
£11.2m - Health Data Research Uk
£731.1k - Industry AVG
Growth
3 year (CAGR) sales growth of -26%, show it is growing at a slower rate (7.2%)
-26% - Health Data Research Uk
7.2% - Industry AVG
Production
with a gross margin of 38.4%, this company has a comparable cost of product (38.4%)
38.4% - Health Data Research Uk
38.4% - Industry AVG
Profitability
an operating margin of -60.1% make it less profitable than the average company (5.2%)
-60.1% - Health Data Research Uk
5.2% - Industry AVG
Employees
with 97 employees, this is above the industry average (18)
97 - Health Data Research Uk
18 - Industry AVG
Pay Structure
on an average salary of £76.1k, the company has a higher pay structure (£26.5k)
£76.1k - Health Data Research Uk
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £115.9k, this is more efficient (£45.8k)
£115.9k - Health Data Research Uk
£45.8k - Industry AVG
Debtor Days
it gets paid by customers after 2442 days, this is later than average (20 days)
2442 days - Health Data Research Uk
20 days - Industry AVG
Creditor Days
its suppliers are paid after 55 days, this is slower than average (18 days)
55 days - Health Data Research Uk
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Health Data Research Uk
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 105 weeks, this is average cash available to meet short term requirements (124 weeks)
105 weeks - Health Data Research Uk
124 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 5%, this is a lower level of debt than the average (22.7%)
5% - Health Data Research Uk
22.7% - Industry AVG
Health Data Research Uk's latest turnover from March 2024 is £11.2 million and the company has net assets of £79.7 million. According to their latest financial statements, Health Data Research Uk has 97 employees and maintains cash reserves of £8.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
---|---|---|---|---|---|---|---|
Turnover | 11,241,000 | 85,623,000 | 64,652,000 | 27,479,776 | 9,699,105 | 8,216,165 | 403,162 |
Other Income Or Grants | |||||||
Cost Of Sales | |||||||
Gross Profit | |||||||
Admin Expenses | |||||||
Operating Profit | |||||||
Interest Payable | |||||||
Interest Receivable | |||||||
Pre-Tax Profit | -6,316,000 | 54,073,000 | 31,752,000 | 91,207 | 55,078 | 110,888 | -28,659 |
Tax | |||||||
Profit After Tax | -6,316,000 | 54,073,000 | 31,752,000 | 91,207 | 55,078 | 110,888 | -28,659 |
Dividends Paid | |||||||
Retained Profit | -6,316,000 | 54,073,000 | 31,752,000 | 91,207 | 55,078 | 110,888 | -28,659 |
Employee Costs | 7,385,000 | 6,517,000 | 5,782,000 | 2,957,175 | 1,448,583 | 793,264 | 272,721 |
Number Of Employees | 97 | 87 | 74 | 37 | 15 | 8 | |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
---|---|---|---|---|---|---|---|
Tangible Assets | 167,000 | 90,000 | 123,000 | 123,213 | 40,472 | 18,018 | |
Intangible Assets | 46,000 | 50,000 | 76,000 | 61,181 | 96,835 | 60,796 | |
Investments & Other | |||||||
Debtors (Due After 1 year) | |||||||
Total Fixed Assets | 213,000 | 140,000 | 199,000 | 184,394 | 137,307 | 78,814 | |
Stock & work in progress | |||||||
Trade Debtors | 75,218,000 | 1,000 | 4,819,000 | 2,421,904 | 93,463 | 574,740 | |
Group Debtors | |||||||
Misc Debtors | 87,220,000 | 28,355,000 | 2,515,601 | 528,415 | 270,741 | 4,676 | |
Cash | 8,502,000 | 8,146,000 | 14,619,000 | 22,729,593 | 16,019,025 | 7,356,288 | 113,346 |
misc current assets | |||||||
total current assets | 83,720,000 | 95,367,000 | 47,793,000 | 27,667,098 | 16,640,903 | 8,201,769 | 118,022 |
total assets | 83,933,000 | 95,507,000 | 47,992,000 | 27,851,492 | 16,778,210 | 8,280,583 | 118,022 |
Bank overdraft | |||||||
Bank loan | |||||||
Trade Creditors | 1,053,000 | 8,591,000 | 2,277,000 | 4,026,657 | 556,223 | 600,513 | 13,968 |
Group/Directors Accounts | |||||||
other short term finances | |||||||
hp & lease commitments | |||||||
other current liabilities | 3,143,000 | 863,000 | 13,735,000 | 23,596,321 | 16,084,680 | 7,597,841 | 132,713 |
total current liabilities | 4,196,000 | 9,454,000 | 16,012,000 | 27,622,978 | 16,640,903 | 8,198,354 | 146,681 |
loans | |||||||
hp & lease commitments | |||||||
Accruals and Deferred Income | |||||||
other liabilities | |||||||
provisions | |||||||
total long term liabilities | |||||||
total liabilities | 4,196,000 | 9,454,000 | 16,012,000 | 27,622,978 | 16,640,903 | 8,198,354 | 146,681 |
net assets | 79,737,000 | 86,053,000 | 31,980,000 | 228,514 | 137,307 | 82,229 | -28,659 |
total shareholders funds | 79,737,000 | 86,053,000 | 31,980,000 | 228,514 | 137,307 | 82,229 | -28,659 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
---|---|---|---|---|---|---|---|
Operating Activities | |||||||
Operating Profit | |||||||
Depreciation | 39,000 | 35,000 | 42,000 | 28,122 | 15,307 | 25,324 | |
Amortisation | 28,000 | 34,000 | 63,000 | 141,600 | 43,315 | 27,054 | |
Tax | |||||||
Stock | |||||||
Debtors | -12,003,000 | 54,047,000 | 28,236,495 | 4,315,627 | -223,603 | 840,805 | 4,676 |
Creditors | -7,538,000 | 6,314,000 | -1,749,657 | 3,470,434 | -44,290 | 586,545 | 13,968 |
Accruals and Deferred Income | 2,280,000 | -12,872,000 | -9,861,321 | 7,511,641 | 8,486,839 | 7,465,128 | 132,713 |
Deferred Taxes & Provisions | |||||||
Cash flow from operations | |||||||
Investing Activities | |||||||
capital expenditure | -131,192 | ||||||
Change in Investments | |||||||
cash flow from investments | -131,192 | ||||||
Financing Activities | |||||||
Bank loans | |||||||
Group/Directors Accounts | |||||||
Other Short Term Loans | |||||||
Long term loans | |||||||
Hire Purchase and Lease Commitments | |||||||
other long term liabilities | |||||||
share issue | |||||||
interest | |||||||
cash flow from financing | -514 | ||||||
cash and cash equivalents | |||||||
cash | 356,000 | -6,473,000 | -8,110,593 | 6,710,568 | 8,662,737 | 7,242,942 | 113,346 |
overdraft | |||||||
change in cash | 356,000 | -6,473,000 | -8,110,593 | 6,710,568 | 8,662,737 | 7,242,942 | 113,346 |
Perform a competitor analysis for health data research uk by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in NW1 area or any other competitors across 12 key performance metrics.
HEALTH DATA RESEARCH UK group structure
Health Data Research Uk has no subsidiary companies.
Ultimate parent company
HEALTH DATA RESEARCH UK
10887014
Health Data Research Uk currently has 17 directors. The longest serving directors include Lord James O'Shaughnessy (Dec 2019) and Mr William Boa (Dec 2021).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Lord James O'Shaughnessy | United Kingdom | 49 years | Dec 2019 | - | Director |
Mr William Boa | England | 61 years | Dec 2021 | - | Director |
Mr Andrew Elder | England | 54 years | Sep 2022 | - | Director |
Dr Claire Bithell | England | 48 years | Sep 2022 | - | Director |
Ms Alison Wilcox | England | 60 years | Sep 2022 | - | Director |
Dr Claire Newland | England | 59 years | Dec 2022 | - | Director |
Dame Julie Moore | England | 66 years | Jul 2023 | - | Director |
Ms Patsy Wilkinson | 63 years | Oct 2023 | - | Director | |
Professor Dame Janet Thornton | England | 76 years | Mar 2024 | - | Director |
Dr Junaid Bajwa | England | 45 years | Apr 2024 | - | Director |
P&L
March 2024turnover
11.2m
-87%
operating profit
-6.8m
0%
gross margin
38.5%
+1.94%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
79.7m
-0.07%
total assets
83.9m
-0.12%
cash
8.5m
+0.04%
net assets
Total assets minus all liabilities
company number
10887014
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
July 2017
age
8
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
HAYSMACINTYRE LLP
address
215 euston road, london, NW1 2BE
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
BIRD & BIRD LLP
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to health data research uk.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for HEALTH DATA RESEARCH UK. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|